Low-Dose Azacitidine Maintenance Therapy Post-Allogeneic Stem Cell Transplantation for High-Risk Pediatric Acute Myeloid Leukemia

被引：0
|
作者：
Tamura, A. [1 ]
Ishida, T. [1 ]
Saito, A. [1 ]
Yamamoto, N. [1 ]
Yokoi, T. [2 ]
Uemura, S. [3 ]
Nino, N. [1 ]
Nakamura, S. [1 ]
Kozaki, A. [1 ]
Kishimoto, K. [1 ]
Hasegawa, D. [1 ]
Kosaka, Y. [1 ]
机构：
[1] Kobe Childrens Hosp, Dept Hematol & Oncol, Kobe, Hyogo, Japan
[2] Osaka Univ Hosp, Dept Pediat, Suita, Osaka, Japan
[3] Kobe Univ Hosp, Dept Pedict, Pedictr, Kobe, Hyogo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-217
引用
收藏
页码：S191 / S191
页数：1
相关论文
共 50 条
  • [31] Acute myeloid leukemia post-allogeneic peripheral stem cell transplant with gastric chloroma
    Rehman, Jalil Ur
    Shinawi, Mohammad
    Aslam, Muhammad
    Kelta, Mouhammad
    ANNALS OF SAUDI MEDICINE, 2011, 31 (06) : 658 - 660
  • [32] Maintenance therapy with decitabine after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and high-risk myelodysplastic syndrome
    Pusic, I.
    Choi, J.
    Bernabe, N.
    Abboud, C.
    Westervelt, P.
    Vij, R.
    Cashen, A.
    Uy, G.
    Stockerl-Goldstein, K.
    Holt, M.
    DiPersio, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S340 - S341
  • [33] Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
    Canichella, Martina
    Molica, Matteo
    Mazzone, Carla
    de Fabritiis, Paolo
    CURRENT ONCOLOGY, 2024, 31 (10) : 6050 - 6060
  • [34] Low-dose decitabine plus venetoclax is safe and effective as post-transplant maintenance therapy for high-risk acute myeloid leukemia and myelodysplastic syndrome
    Wei, Yunxiong
    Xiong, Xia
    Li, Xin
    Lu, Wenyi
    He, Xiaoyuan
    Jin, Xin
    Sun, Rui
    Lyu, Hairong
    Yuan, Ting
    Sun, Tongtong
    Zhao, Mingfeng
    CANCER SCIENCE, 2021, 112 (09) : 3636 - 3644
  • [35] A Phase 2 Study of Glasdegib for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with High Risk of Post-Allogeneic Stem Cell Transplantation Relapse
    Kent, Andrew
    Vasu, Sumithira
    Schatz, Derek
    Monson, Natalie
    Devine, Steven
    Smith, Clayton
    Gutman, Jonathan A.
    Pollyea, Daniel A.
    BLOOD, 2019, 134
  • [36] Comparative analysis of hypomethylating agents as maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia
    Li, Li
    Zhang, Ran
    Cao, Weijie
    Bian, Zhilei
    Qin, Yang
    Guo, Rong
    Zhang, Suping
    Peng, Yingnan
    Wan, Dingming
    Ma, Wang
    LEUKEMIA & LYMPHOMA, 2023, 64 (13) : 2113 - 2122
  • [37] Maintenance therapy for high-risk acute leukemia after allogeneic hematopoietic cell transplantation: wait a minute
    Soiffer, Robert J.
    BLOOD ADVANCES, 2020, 4 (13) : 3205 - 3208
  • [38] Azacitidine As a Post-Stem Cell Transplant Maintenance for Children with Acute Myeloid Leukemia
    Onishi, Toshihiro
    Skiles, Jodi L.
    Goebel, W. Scott
    Robertson, Kent
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S118 - S119
  • [39] Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia
    Tsirigotis, Panagiotis
    Gkirkas, Konstantinos
    Kitsiou, Vassiliki
    Chondropoulos, Spiros
    Athanassiades, Theofilos
    Thomopoulos, Thomas
    Tsirogianni, Alexandra
    Stamouli, Maria
    Karagiannidi, Aggeliki
    Siafakas, Nikolaos
    Pappa, Vassiliki
    Nagler, Arnon
    CANCERS, 2021, 13 (11)
  • [40] Outcome and Prognostic Factors of High-Risk Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Zhu, Cheng-ying
    Chen, Guo-feng
    Zhou, Wei
    Hou, Cheng
    Wang, Xiao-kai
    Wang, Fei-yan
    Yang, Nan
    Wang, Li
    Fang, Shu
    Luo, Lan
    Guan, Li-xun
    Zhang, Ran
    Liu, Yu-chen
    Dou, Li-ping
    Gao, Chun-ji
    ANNALS OF TRANSPLANTATION, 2019, 24 : 328 - 340
12345